The Politics Of Health: Feature ArticleFDA Collaboration with Big Pharma Raises EyebrowsThursday, June 07, 2007Byron Richards, CCN The Andrew von Eschenbach FDA era is upon us. The Avandia scandal is the tip of the iceberg. Is anyone ready? The words “illicit financial collusion” have been replaced by the politically correct term, “collaboration.” On May 30, in defense of his cozy relationship with Big Pharma and Big Biotech von Eschenbach told reporters, “This is a collaboration, but it’s not just a collaboration with drug companies, it’s a collaboration with academia and with other agencies.” And he forgot to include that it is also a collaboration with various Senators, such as Senator Bennett (R-UT) and Senator Hatch (R-UT), as can be seen by the highly lucrative Critical Path Initiative program for cardiovascular disease research at the University of Utah. Plainly stated, the FDA is set on becoming a drug company involved in every aspect of drug development for the next century. This pipe dream involves using sophisticated FDA software and related technologies to set the standards for the future of medicine, which will soon require your DNA in an FDA-owned supercomputer if you would like medical care. The FDA will help design all drugs from the ground up. The FDA, through the Reagan-Udall Foundation for the FDA, will control all patents and licensing arrangements regarding the drugs that are developed. Under this plan the fox will not only be in charge of the henhouse, the fox will eat hens at will. Privacy issues, genetic discrimination, and required implantable RFID chips will be the order of the day. Billions of dollars are at stake. Wall Street can’t wait. Drug safety and the health options of all Americans hang somewhere in the balance, including access to safe and effective dietary supplements (the only true competition). What will the FDA do when safety problems surface in the drugs it develops? Will the FDA put consumer safety ahead of its own financial interests? What legal liability will the FDA face when their drugs injure or kill? The FDA has already thought this through and is doing what it can to make sure citizens have no rights to sue when injured by FDA-approved medications. Senators have already approved this FDA plan as part of the recently passed S.1082 – without asking a single question about it! The battle now moves to the House (HR.2900). A hurdle has been placed in front of the FDA, the unfortunately timed Avandia scandal is prying open the door to FDA and industry financial collusion, wherein tens of thousands of people die based on FDA management decisions while Big Pharma makes billions. It is time for Americans to wake up, as your health options are about to seriously diminish. The Avandia Scandal On June 6, 2007 von Eschenbach and various FDA employees testified before Henry Waxman’s (D-CA) Committee on Oversight and Reform. Waxman set the tone by reviewing the FDA history of Avandia approval and post marketing activities, outlining what he called “a number of missed opportunities.” Von Eschenbach skirted all issues by saying the FDA is still reviewing data and will hold an advisory committee hearing on July 30, thus attempting to delay the spotlight on this scandal so that HR.2900 can come to the floor of the House without the Avandia scandal hanging over its head. The Avandia scandal is becoming quite a dog and pony show. On June 6, 2007 the New York Times revealed a stunning event that occurred in March of 2006 wherein FDA safety supervisor Dr. Rosemary Johann-Liang approved a black box warning on Avandia to warn about the risk for congestive heart failure. The von Eschenbach team ordered her to retract her approval of the warning. She was then stripped of her power to make such warnings and removed from supervision of the safety of Avandia. In other words, FDA management actively blocked a needed public warning regarding the dangers of this drug, consistent with eight years of FDA failures to ensure proper post-marketing studies of Avandia regarding heart attack risk. Of particular interest is the FDA’s technical defense of its position regarding the approval of the drug in the first place. The drug was approved based on a “biomarker” or surrogate endpoint – meaning that approval of the drug was based on its ability to change blood sugar levels, not whether it improved the health of a diabetic. Avandia works by throwing a gene switch known as PPAR that is involved with multiple chemistry reactions at the cellular level, a fundamentally unpredictable and powerful drug target. By focusing on the biomarker called blood sugar the FDA was able to ignore the key safety question which was, “At what expense to health is blood sugar being lowered?” It now turns out that Avandia has a whopping 43% increased risk for heart attacks as well as an increased risk of death from using the drug. This information is only coming to light after eight years of use. The FDA sat on the heart attack risk data and failed to warn the public, enabling the drug to become a blockbuster and rake in 3.2 billion in annual sales. GlaxoSmithKline made no proper effort to determine the heart attack risk of Avandia in proper post-marketing studies, which the FDA condoned. And as stated in the testimony of Bruce Psaty, MD, “FDA failed to warn or inform in timely manner.” It is important to understand that the future of all drug development under the Critical Path Initiative and the Reagan-Udall Foundation for the FDA will rely on this type of biomarker evaluation (surrogate endpoints) to rush drugs to the market faster with virtually no proof of desired clinical outcomes. The American public will then be subject to a safety experiment. This approach to new drug development will sentence unsuspecting citizens in our country to a never-ending stream of Avandia-like scandals. I’ll Stroke Your Back, You Stroke Mine
It is not an accident that Andrew von Eschenbach’s permanent appointment to head the FDA was slipped through at the end of last year during the Lame Duck session, with most Senators asleep at the wheel. About the only Senator not sleeping was Charles Grassley (R-IA), who stated during von Eschenbach’s confirmation hearing:
As Grassley’s warning fell on deaf ears Orrin Hatch (R-UT) rose in defense of von Eschenbach:
Apparently we got what we deserve. Why was Hatch so adamant about placing a bio-tech sales rep at the top of the FDA? Hatch is a large recipient of Big Pharma money. He holds a key position on the HELP committee that created Senate bill S.1082. He is currently designing legislation to protect Big Pharma and Big Biotech from generic competition in the next generation of biological drugs – a windfall worth billions for the industry. Hatch wants to place this legislation into S.1082/HR.2900 as an amendment when the bill goes to conference committee. It is obvious that Hatch has his hand in the Big Pharma cookie jar. Von Eschenbach is certainly playing his role in rewarding Hatch for his support, helping us to gain a clear picture of what von Eschenbach means by “collaboration.” On June 1, 2007, von Eschenbach was in Utah promoting a new Critical Path Initiative project with the University of Utah. It is called the Cardiovascular Drug Safety and Biomarker Research Program. This project could be worth hundreds of millions, even billions of dollars to the state of Utah. I wonder why the FDA chose Utah for this no-bid contract known as a collaboration? Hatch Walks an Interesting Fence A key problem with S.1082 is that it contains a sneak attack on dietary supplements that will enable the FDA to remove helpful dietary supplements from the market at its whim in order to protect drugs from competition. This is being done through trick language the FDA has installed in bill S.1082, specifically relating to the Critical Path Initiative and the Reagan-Udall Foundation for the FDA. Because there are many dietary supplement companies in Utah, Hatch has also been a major supporter of the dietary supplement industry and is responsible, along with Tom Harkin (D-IA) for the law known as DSHEA which provides access to dietary supplements in this country. In the past month Hatch and Harkin were flooded with objections and concerns regarding this sneak attack on dietary supplements. This led to a conversation between Hatch, Harkin, Kennedy, and Enzi wherein they state that S.1082 will not affect dietary supplements. HOWEVER, UNTIL THE LANGUAGE IS CHANGED IN THE BILL ITSELF THE THREAT TO DIETARY SUPPLEMENTS IS VERY REAL AND IS A HUGE PROBLEM. This is fully explained by Jonathan Emord, our nation’s leading health freedom attorney, in an interview he recently had with me that can be heard by clicking here. The Senator’s conversation, called a colloquy, has been used by the Natural Products Association (NPA) to neutralize concerns of its health food stores regarding this issue. It is obvious that NPA takes its marching orders from Hatch. Why are Hatch and the NPA trying to convince consumers that they are protected when nothing could be further from the truth? I’ve asked this question to David Seckman, head of NPA, and received no answer. It is quite a disservice to the dietary supplement industry when leaders pretend real problems do not exist. Hatch takes in more money from Big Pharma than he does from dietary supplement companies – and as a veteran politician he walks both sides of the fence with considerable skill. It is vital that Hatch and Harkin help change the language within Senate bill S.1082 to actually protect dietary supplements. This will require a major public demand, in both the House and to these Senators, to make this happen. You can take action now by clicking here.
© 2007 Truth in Wellness, LLC - All Rights Reserved
Byron J. Richards, Founder/Director of Wellness Resources, is a Board-Certified Clinical Nutritionist and nationally-renowned health expert, radio personality, and educator. He is the author of Mastering Leptin, The Leptin Diet, and Fight for Your Health: Exposing the FDA’s Betrayal of America. Richards encourages individuals to take charge of their health, stand up for their health rights, and not blindly succumb to propaganda from the vested-interests who profit from keeping Americans sick. As founder of Wellness Resources, Inc. of Minneapolis, MN, an independently-owned fine-quality dietary supplement company since 1985, he has personally developed 75 unique nutraceutical-grade nutritional formulas. http://www.wellnessresources.com
FREE Subscription to Byron’s Health Newsletter, click here.
Other Feature Articles:
The shocking death of Tim Russert last Friday has left an entire nation wondering what happened. He was a model patient, doing everything his doctors asked. All major media have run articles trying to explain the nuances and difficulties in treating coronary artery disease. These articles find little fault in Russert’s care, trying to create the idea that his heart attack was just too hard to predict and that all that could have been done for him was done. I beg to differ. His death represents the failure of standard medical care to produce a positive result – an occurrence that is all too common in today’s world.
Legions of well wishers look on as Senator Ted Kennedy struggles for his life, fighting against one of the most difficult types of brain tumors. Ironically, it may be the drugs he has so adamantly promoted that are the straw that broke the camel’s back, leading to his brain tumor.
The latest stone thrown at the 200-billion-dollar-a-year cell phone industry came from a study by neurosurgeon Vini G. Khurana entitled Mobile Phone-Brain Tumour: Public Health Advisory. His meta-analysis of existing cell phone studies may not contain a lot of new information; but his rather alarming message was carried by media around the world: “there is a growing body of statistically significant evidence for a relationship between the overall length of use of a mobile phone and the delayed occurrence of a brain tumor on the same side of the head as the ‘preferred side’ for mobile phone usage.” He claimed a 2-4 fold increased risk following 10 years of regular use.
On April 2, 2008 CNN spent the day bringing awareness to the problem of autism. Larry King’s segment, which included Jenny McCarthy along with a panel of guests, was particularly enlightening. My hat is off to Jenny, a celebrity mother who is making it quite uncomfortable for the Center for Disease Control (CDC) to ignore parents of autistic children seeking answers. Why does a mom have to do the work of the CDC? The answer is rather simple: our government’s zeal to insist on too many vaccines while ignoring the actual risks is the driving force behind the autism tragedy.
The Senate is about to approve legislation (Mothers Act – S.1375) which mandates the indoctrination of pregnant and nursing mothers into the use of extremely dangerous psychiatric medication. We already know this class of medication poses serious health risks to both mother and baby. Consequences to the baby are now proven to cause nerve-related changes that can adversely affect health for a lifetime.
Immediate Consumer Action is Needed to Stop Mothers Act The Mothers Act is pending legislation that will indoctrinate hundreds of thousands of mothers into taking dangerous psych drugs. It is a great example of how the Big Pharma lobby controls Congress to the detriment of health, as well as needlessly and dramatically inflating the costs of our health care system for everyone. Like any piece of legislation it purports to address a troubling issue – in this case the mood distress of mothers following birth known as postpartum depression. It is true that 10% - 15% of women need some assistance in dealing with this topic – but the majority of them sure don’t need it from Big Pharma. That is the Big Lie.
It now appears that the FDA Chief Andrew von Eschenbach, M.D. has committed perjury before Congress. Unlike Roger Clemens, who also seems to be putting his foot in his mouth before Congress, von Eschenbach’s actions appeared to have allowed unnecessary deaths to Americans – hardly the mission of the FDA. By contrast, Roger Clemens is simply causing death to his own reputation. Hopefully Congress can quit wasting taxpayer money on baseball and get to the bottom of what is really going on at the FDA.
Several high profile human cardiovascular drug experiments have turned into disasters for Big Pharma. These findings are sure to shake the misguided consumer confidence in drugs as a mainstay of preventive cardiovascular health. Hanging in the balance are billions of dollars of fraudulent drug sales based on the flimsy argument that changing numbers (blood sugar, cholesterol, or blood pressure) with the use of toxic drugs is somehow the same as actually being healthy…
Women across the country are being duped to consume billions of dollars worth of bone poisons under the false pretense that if they take them long enough they will not develop osteoporosis. Even the FDA is becoming alarmed by the side effects of these bone drugs. The biggest selling drug in this class is called Fosamax, made by Merck – the very same company that killed thousands of Americans with Vioxx while hiding cardiovascular risks from the FDA and patients. Does anyone trust them?…
Considering that tens of millions of Americans now take statins to lower cholesterol, the following headline was conspicuously absent from the major media this month: “Statins Found to Turn On Gene that Causes Muscle Damage.” It’s now a fact of science; a new study shows that taking statins destroys your muscle to a greater or lesser degree. And let’s not forget that the heart is a muscle.
On November 29, 2007 the FDA made a rather surprising, almost honest announcement. It said that it could not protect Americans from the dangers of drugs. A 56-page report by its Subcommittee on Science and Technology stated the FDA “suffers from serious scientific deficiencies and is not positioned to meet current or emerging regulatory responsibilities.” This blistering report on the life-threatening shortcomings of the FDA was released with the stamp of approval of the head of the FDA, Commissioner Andrew von Eschenbach. The flagrant disregard for human health by the FDA…
Oprah has done an immense favor to millions of American women by helping them understand that a malfunctioning thyroid gland may indeed be part of their weight and health problems. After writing openly about her thyroid problem in the October 2007 Oprah Magazine, she then went into the nature of thyroid problems on her TV show.
The United States Health Freedom Assembly met October 12 – 14, 2007 at the William Mitchell College of Law in Saint Paul, MN, a gathering of many of the top state, federal, and international health freedom advocates, organizations, and industry. The meeting took on a tone of extreme importance as the FDA has issued policy and obtained broad new regulatory authority over health freedom in the past 12 months. The FDA is seeking to undermine the law known as DSHEA (Dietary Supplement Health and Education Act of 1994), the cornerstone of health freedom in America. Emboldened by its new powers the FDA is now poised to trample the first amendment rights of companies and Americans who seek to explain or understand how nutrition can support health. The FDA campaign has begun.
On Wednesday, July 11, 2007 the House passed HR.2900 without allowing the Ron Paul (R-TX) amendments to protect dietary supplements. Representatives Frank Pallone, Jr. (D-NJ), John Dingell (D-MI), Henry Waxman (D-CA), and others falsely proclaimed that they were doing America a favor by passing this sweeping FDA-supported legislation that grants the rouge agency more power and money, and even transforms it into a quasi drug company.
The FDA, emboldened by its transformation into a drug company, has embarked upon an anti-American plan of interfering with business and intentionally eliminating various dietary supplement companies from the market. The FDA announcement came on Friday, June 22, 2007 under the guise of a final rule for dietary supplement good manufacturing practices (CGMPs). Within this 800 page rule the FDA states, “We find that this final rule will have a significant economic impact on a substantial number of small entities.... Establishments with above average costs, and even establishments with average costs, could be hard pressed to continue to operate. Some of these may decide it is too costly and either change product lines or go out of business.... 140 very small [less than 20 employees] and 32 small dietary supplement manufacturers [less than 500 employees] will be at risk of going out of business.... costs per establishment are proportionally higher for very small than for large establishments....The regulatory costs of this final rule will also discourage new small businesses from entering the industry.”
Under the false pretense of improved food and drug safety the FDA is re-inventing itself as a kingpin drug company. This charade has so far hoodwinked virtually all members of Congress. The Senate has already approved this FDA transformation. The House will bring similar legislation out of committee next week, with a vote in the full House likely in July.
The Andrew von Eschenbach FDA era is upon us. The Avandia scandal is the tip of the iceberg. Is anyone ready? The words “illicit financial collusion” have been replaced by the politically correct term, “collaboration.”
The penalty in China is death, in America its business as usual. Zheng Xiaoyu, the former head of China’s FDA, was sentenced to death for accepting $832,000 in drug company bribes and for dereliction of duty. Like China, our country is in the middle of a drug and food safety crisis. Why is FDA Commissioner Andrew von Eschenbach, M.D. getting a free pass? Why did the Senate just pass legislation (S.1082) that gives von Eschenbach significantly more power to do whatever he pleases? And exactly what is it that von Eschenbach is doing?
Senate Attempts Damage Control – House Braces for Onslaught Senators were taken off guard by the public outrage over the passing of bill S.1082 with language that can be used to seriously harass dietary supplements by enabling the FDA to apply drug-related risk analysis to the safety of food and food ingredients (and thus dietary supplements).
The FDA is Acquiring New Powers to Suppress Alternative Health Your right to have free access to safe and highly effective dietary supplements is under an intense multi-pronged FDA attack. On May 14, 2007 the Supreme Court sided with the FDA by deciding not to hear the case of Nutraceutical v FDA, letting stand a federal appeals court ruling that permits the FDA to use drug-related risk/ benefit analysis to determine if a nutrient is safe.
The Senate has sold out the American people. Anyone voting for change in the last election can now plainly see the shenanigans of a Democratic-controlled Senate. Under Republicans no FDA reform ever took place. Big Pharma owns so many Republicans that all meaningful legislation to curtail the deaths and injuries of American citizens at the hands of Big Pharma and the FDA had been completely thwarted for the past six years. Under Democratic control sweeping FDA reform favorable to Big Pharma was proposed and the majority of meaningful reform was blocked or seriously watered down. Which is worse? As Kennedy stated in his opening remarks today, S1082 (the Kennedy/Enzi FDA bill) was an “elaborate scheme.”
For approximately four days Americans lived in a delusional state that they may soon pay drug prices the same as every other country in the civilized world. Euphoria over breaking the Big Pharma monopoly turned to disgust as the chameleon, Senator Edward Kennedy (D-MA), changed sides and lead a contingency of Democrats against fellow Democrats lead by Byron Dorgan (D-ND). By passing the Cochran amendment the Dorgan amendment is poisoned and will no longer be effective. Maybe Democrats are now learning what Republicans have known for some time – you can’t trust Kennedy.
In May of 2006, after months of research and investigation, I published my ominous findings in the book Fight for Your Health: Exposing the FDA’s Betrayal of America. Everything I predicted in this book is on the fast track to becoming reality. A majority of Americans, not informed on current events and unaware of the history involved, are silent. Mainstream media, one of Big Pharma’s largest clients, is silent. Only the power of the internet, which rivals the invention of the printing press in significance, is making it possible for individuals to understand what is going on.
There is still time to stop FDA, Inc. Bill S1082 is a bill that helps fund the FDA with Big Pharma money. It is known all over Capital Hill as Big Pharma-designed legislation. It is running into all sorts of credibility problems. A vote is likely on Monday – delayed due to all the opposition flooding the Senate by “we the people.”
S1082 Update – Tuesday’s Activity. Fight Erupts on Senate floor: As the Senate continues to debate the Big Pharma-friendly sweeping reform of the FDA a new problem for Big Pharma’s prize Senators has erupted and quickly turned into confrontation on the floor of the Senate. At stake is at least 10 billion dollars per year in exorbitant Big Pharma profits. In one corner is Big Pharma-puppet Orrin Hatch (R-UT), representing the Kennedy/Enzi drug cartel. In the other corner is a majority of Senators lead by Byron Dorgan (D-ND).
The combination of a lack of sun and cold weather invariably strains your mood as well as your metabolism. It is an energy-depleting form of stress, similar to having a daily argument with someone. If your energy systems…
S1082 Update – Monday’s Activity at the bottom of this article. Bill S1082: The Food and Drug Administration Revitalization Act (also called the Prescription Drug User Fee Act of 2007) is one of the greatest scams and con jobs ever foisted on the American public. Current FDA management is grossly incompetent on the subject of drug safety.
A new attack against health freedom, drug safety, and dietary supplements was launched last week by Senator Edward Kennedy (D-MA) with major support from Michael Enzi (R-WY). It is called the Food and Drug Administration Revitalization Act (S1082). This legislation was planned over the past few years working hand-in-glove with the FDA’s dysfunctional management and legal team – meaning this legislation was written for the profits of Big Pharma and Big Biotech AT THE EXPENSE OF SAFETY AND HUMAN HEALTH.
Americans are up in arms that our pets are being injured and killed by a toxin sent to America by a Chinese company. Melamine, a toxic fertilizer used in China, is the suspected culprit behind the deaths and injuries to potentially hundreds of thousands of our pets. The FDA assures us that this toxin has not entered the human food supply – does anyone believe in the competence of the FDA? It is only a matter of time before this type of problem happens to humans, as the inept FDA has no control over imported food intended for humans, let alone pets.
On February 13, 2007 the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations opened hearings lambasting the FDA regarding the safety of drugs. The opening statement by Chairman John Dingell (D-MI) set the tone, “It is clear … that the FDA is badly broken. I expect that before we finish this investigation, which is just getting underway, we will discover whether the problems we have found are due to the work of scoundrels, irrational penny-pinching, or because the doors to the FDA “hen house” have been thrown open to foxes. It may be a combination of all three.”
Wall Street, international bankers, President Bush, pharmaceutical companies, new biotech companies, the Rockefeller empire, and the FDA have created a new plan for public health. It is a grand vision based on profit. It will use the FDA and, as needed, the Department of Homeland Security as the regulatory police force that ensures compliance in the name of public safety. Legitimate objections may be overpowered in the name of national security.
|
| Home > Health News > The Politics Of Health: Feature Article |
